Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Read-out on NIH deal inquiry

A hearing on co-development licensing agreements between NIH-funded non-profit research institutions and private companies is scheduled for June 17 before the House subcommittee on regulation, business opportunities and technology, committee staff member Steve Jenning told BioCentury.

Read the full 376 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers